Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | PFSI | PENNYMAC FINL SVCS INC NEW | Financial Services | 2,339.0 | $308K | 0.14% | NEW | — | $131.84 | -35.0% |
| 182 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 57,253.0 | $307K | 0.14% | NEW | — | $5.37 | -65.9% |
| 183 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 14,121.0 | $306K | 0.14% | -14K | -49.0% | $21.70 | +35.0% |
| 184 | URGN | UROGEN PHARMA LTD | Healthcare | 12,806.0 | $300K | 0.14% | -8K | -38.2% | $23.42 | +22.9% |
| 185 | U | UNITY SOFTWARE INC | Technology | 6,734.0 | $297K | 0.13% | NEW | — | $44.17 | -38.5% |
| 186 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 23,984.0 | $291K | 0.13% | NEW | — | $12.14 | -24.5% |
| 187 | — | BENITEC BIOPHARMA INC | — | 20,753.0 | $280K | 0.13% | NEW | — | $13.47 | — |
| 188 | — | FORTE BIOSCIENCES INC | — | 10,146.0 | $277K | 0.12% | NEW | — | $27.27 | — |
| 189 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 17,466.0 | $275K | 0.12% | NEW | — | $15.77 | -15.0% |
| 190 | — | AVALO THERAPEUTICS INC | — | 15,087.0 | $274K | 0.12% | NEW | — | $18.16 | — |
| 191 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 6,605.0 | $274K | 0.12% | NEW | — | $41.43 | -38.3% |
| 192 | PRTA | PROTHENA CORP PLC | Healthcare | 28,589.0 | $273K | 0.12% | NEW | — | $9.55 | +2.2% |
| 193 | OSCR | OSCAR HEALTH INC | Healthcare | 18,976.0 | $273K | 0.12% | NEW | — | $14.37 | +62.3% |
| 194 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 7,416.0 | $269K | 0.12% | NEW | — | $36.29 | -24.6% |
| 195 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 460.0 | $267K | 0.12% | NEW | — | $579.45 | -24.4% |
| 196 | QURE | UNIQURE NV | Healthcare | 11,014.0 | $264K | 0.12% | NEW | — | $23.93 | +13.0% |
| 197 | RPRX | ROYALTY PHARMA PLC | Healthcare | 6,594.0 | $255K | 0.11% | NEW | — | $38.64 | +36.8% |
| 198 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 47,108.0 | $254K | 0.11% | +36K | +311.8% | $5.40 | -29.3% |
| 199 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 11,029.0 | $254K | 0.11% | +9K | +429.7% | $23.00 | +8.7% |
| 200 | — | INOVIO PHARMACEUTICALS INC | — | 142,164.0 | $247K | 0.11% | NEW | — | $1.74 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
56.7%
Technology
14.5%
Financial Services
14.2%
Consumer Cyclical
3.6%
Communication Services
3.5%
Energy
3.5%
Basic Materials
3.0%
Consumer Defensive
0.6%
Industrials
0.4%